Prof. Jürgen Kohlhase New Director Human Genetics of Centogene

Freiburg, Rostock (Germany), Vienna (Austria), (PresseBox) - Centogene Holding AG, parent company of a group of diagnostic laboratories, announced today that Prof. Jürgen Kohlhase, MD, Founder of the Center of Human Genetics Freiburg, Germany, became cooperation partner of Centogene Holding AG and was appointed Director Human Genetics.

Internationally the group operates under the name of Centogene as an active global leader in the field of molecular diagnostics for Rare Diseases. The German market will be serviced by the Center of Human Genetics Freiburg.

Prof. Jürgen Kohlhase is a Board Certified (Germany) Specialist in Human Genetics and honorary Professor for Human Genetics at the University of Freiburg. After graduating from Medical School, he obtained scientific and medical training from 1993 to 1995 at the Max-Planck Institute for Biophysical Chemistry in Göttingen and the Institute for Human Genetics at the University of Göttingen, Germany. Between 1995 and 1996 he worked as medical resident in Human Genetics at the Universities in Gießen and Göttingen. In 2002, he received his Board Certificate in Human Genetics and worked as an assistent professor at the University of Göttingen. From 2003 to 2006 he was Head of Department at the Institute for Human Genetics and Anthropology at the University of Freiburg. In 2006 he founded the Center of Human Genetics Freiburg where he acts as lab director and clinical specialist.

Prof. Kohlhase is a widely known expert in the field of Human Genetics and co-authored more than 100 scientific articles. Prof. Kohlhase is a member of the German Society of Human Genetics (GfH), the German Society of Medical Geneticists (BVDH), the American Society of Human Genetics and the European Society of Human Genetics. He is also a member of the scientific committee of the GfH.

Awards/ honors: Award of the German Society of Human Genetics (GfH) 1998; Frank-Majewski Award 2007; Rare disease day USA Hall of Fame 2010.

"With Jürgen Kohlhase we significantly strengthen and enlarge our clincal and analytical expertise with special emphasis in developmental disorders and malformation syndromes, oncology, dermatology, connective tissue diseases as well as in other genetic disorders, and we establish an important foothold in our home market Germany." commented Prof. Dr. Arndt Rolfs, founder and Head of the Supervisory Board, professor of Neurology and Psychiatry at the University of Rostock and head of the Albrecht- Kossel-Institute for Neuroregeneration, both Rostock, Germany.

Centogene AG

Centogene, a group of companies, financed entirely without venture capital, has become a global leader among laboratories in the field of diagnosing rare diseases, particularly in the area of congenital diseases of metabolism, neurological disorder, cardiology, oncology, dermatology and bone diseases. Centogene offers high end genetic and biochemical analysis of medical samples. Very short standard turn around times below three weeks with interpretation and recommendation by a team of medical experts accompany every analysis. With active laboratories in Rostock, Vienna and Freiburg the group offers almost 1000 different genetic analysis worldwide.

Press releases you might also be interested in

Subscribe for news

The subscribtion service of the PresseBox informs you about press information of a certain topic by your choice at a choosen time. Please enter your email address to receive the email with the press releases.

An error occurred!

Thank you! You will receive a confirmation email within a few minutes.

I want to subscribe to the gratis press mail and have read and accepted the conditions.